BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17028108)

  • 21. Beta blockers in systolic heart failure.
    Jackowski L; Azam R
    Aust Fam Physician; 2008 Mar; 37(3):137-9. PubMed ID: 18345362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenesis and treatment of cardiomyopathy.
    Fonarow GC
    Adv Intern Med; 2001; 47():1-45. PubMed ID: 11795071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral arterial disease: a review of disease awareness and management.
    Watson K; Watson BD; Pater KS
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GPs have pivotal role in managing CHF.
    Witte KK; Clark AL
    Practitioner; 2008 Jun; 252(1707):29-30, 32, 34 passim. PubMed ID: 18669368
    [No Abstract]   [Full Text] [Related]  

  • 26. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic heart failure.
    Poole-Wilson PA
    Timely Top Med Cardiovasc Dis; 2007 Jan; 11():E2. PubMed ID: 18297148
    [No Abstract]   [Full Text] [Related]  

  • 28. Optimal management of chronic heart failure in patients with chronic kidney disease.
    Zachariah D; Kalra PA; Kalra PR
    J Ren Care; 2009 Mar; 35(1):2-10. PubMed ID: 19200271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal treatment of hypertension with diastolic heart failure.
    Susic D; Frohlich ED
    Heart Fail Clin; 2008 Jan; 4(1):117-24. PubMed ID: 18313629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension with acute coronary syndrome and heart failure.
    Diercks DB; Ohman EM
    Ann Emerg Med; 2008 Mar; 51(3 Suppl):S34-6. PubMed ID: 18191288
    [No Abstract]   [Full Text] [Related]  

  • 31. Heart failure and diabetes: pathogenesis and management.
    Kamalesh M
    Minerva Med; 2006 Jun; 97(3):231-9. PubMed ID: 16855518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High output heart failure.
    Mehta PA; Dubrey SW
    QJM; 2009 Apr; 102(4):235-41. PubMed ID: 18990720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart failure in women: a need for prospective data.
    Hsich EM; PiƱa IL
    J Am Coll Cardiol; 2009 Aug; 54(6):491-8. PubMed ID: 19643307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response?
    Chong AY; Lip GY
    Eur J Heart Fail; 2007 Feb; 9(2):124-8. PubMed ID: 16859990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic management of heart failure caused by systolic dysfunction.
    Chavey WE; Bleske BE; Van Harrison R; Hogikyan RV; Kesterson SK; Nicklas JM
    Am Fam Physician; 2008 Apr; 77(7):957-64. PubMed ID: 18441861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
    Jneid H; Moukarbel GV; Dawson B; Hajjar RJ; Francis GS
    Am J Med; 2007 Dec; 120(12):1090.e1-8. PubMed ID: 18060931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
    Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
    Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA; Gheorghiade M
    Heart Fail Clin; 2005 Apr; 1(1):77-93. PubMed ID: 17386836
    [No Abstract]   [Full Text] [Related]  

  • 39. Aspirin and clopidogrel treatment impair nitric oxide biosynthesis by platelets.
    O'Kane PD; Reebye V; Ji Y; Stratton P; Jackson G; Ferro A
    J Mol Cell Cardiol; 2008 Aug; 45(2):223-9. PubMed ID: 18606420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
    Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.